EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H19Cl2F3N6O3 |
| Net Charge | 0 |
| Average Mass | 543.333 |
| Monoisotopic Mass | 542.08478 |
| SMILES | C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 |
| InChI | InChI=1S/C22H19Cl2F3N6O3/c1-12(34)19-28-18(29-33(19)16-4-2-3-15(24)9-16)11-32-21(36)31(10-17(35)22(25,26)27)20(30-32)13-5-7-14(23)8-6-13/h2-9,12,17,34-35H,10-11H2,1H3/t12-,17-/m0/s1 |
| InChIKey | AZXOTZCWQDJCLY-SJCJKPOMSA-N |
| Roles Classification |
|---|
| Application: | cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pecavaptan (CHEBI:757929) has role cardiovascular drug (CHEBI:35554) |
| pecavaptan (CHEBI:757929) is a ring assembly (CHEBI:36820) |
| pecavaptan (CHEBI:757929) is a triazoles (CHEBI:35727) |
| INN | Source |
|---|---|
| pecavaptan | WHO MedNet |
| Synonyms | Source |
|---|---|
| BAY 1753011 | ChEMBL |
| BAY-1753011 | ChEMBL |